跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Alprostadil for Injection
Approved
化学药品
Alprostadil for Injection
UCB Pharma GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jan 24, 2018
Approval ID
7MazXbVXwOX
Company
UCB Pharma GmbH
Type
化学药品
Approval Details
Approval Id
7MazXbVXwOX
Approval Number
H20181056
Generic Name
注射用前列地尔
Generic Name En
Alprostadil for Injection
Trade Name
保达新
Drug Type
化学药品
Dosage Form
注射剂
Strength
20μg
Reg Date
2018-01-24
Expired Date
2023-01-23
Company Name
UCB Pharma GmbH
Company Address
Alfred-Nobel-Str.10,40789 Monheim,Germany
Production Company Name
Bayer Pharma AG
Production Company Address
Kaiser-Wilhelm-Allee 51368 Leverkusen,Germany
Company Detail Path
/organization/ucb-pharma-gmbh
Production Company Detail Path
/organization/bayer-pharma-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 24, 2018
Approval ID
7MazXbVXwOX
Type
化学药品
Back to NMPA Approvals
保达新 - NMPA Drug Approval Details